OPAL Clinical Program

ACR=American College of Rheumatology; BID=twice daily; CASPAR=Classification Criteria for Psoriatic Arthritis; csDMARD=conventional synthetic disease-modifying antirheumatic drug; DMARD=disease-modifying antirheumatic drug; DSS=Dactylitis Severity Score; FACIT-F=Functional Assessment of Chronic Illness Therapy-Fatigue; HAQ-DI=Health Assessment Questionnaire-Disability Index; IR=inadequate responder; JAK=Janus kinase; LEI=Leeds Enthesitis Index; MOA=mechanism of action; PASI=psoriasis area and severity index; PsA=psoriatic arthritis; q 2 wk=every 2 weeks; RA=rheumatoid arthritis; SC=subcutaneously; SF-36=Medical Outcomes Study 36-Item Short-Form Health Survey; TNFi=tumor necrosis factor inhibitor.